S
AVNS icon

Sachetta’s Avanos Medical AVNS Stock Holding History

Sachetta’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25 Hold
1
– – ﹤0.01% 1018
2026
Q1 		$15 Hold
1
– – ﹤0.01% 1067
2025
Q4 		$12 Hold
1
– – ﹤0.01% 1022
2025
Q3 		$12 Hold
1
– – ﹤0.01% 1066
2025
Q2 		$13 Hold
1
– – ﹤0.01% 1091
2025
Q1 		$15 Sell
1
-3
-75% -$47 ﹤0.01% 1108
2024
Q4 		$64 Sell
4
-3
-43% -$59 ﹤0.01% 1167
2024
Q3 		$169 Hold
7
– – ﹤0.01% 1182
2024
Q2 		$161 Sell
7
-7
-50% -$136 ﹤0.01% 1204
2024
Q1 		$315 Hold
14
– – ﹤0.01% 1099
2023
Q4 		$315 Buy
+14
New +$289 ﹤0.01% 1099

Other funds holding AVNS

SRC
Samson Rock Capital London, United Kingdom $45.6M AUM 86.17% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Sachetta's AVNS Position: Q2 2026 in Review

Sachetta held its Avanos Medical (AVNS) position steady in Q2 2026 at 1 share worth $25. The position accounts for ﹤0.01% of the portfolio, ranked #1018.

Sachetta first reported a position in AVNS in Q4 2023 and has held it in 11 quarters since. The position peaked at $315 in Q1 2024. 26 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Sachetta held 1 share of Avanos Medical worth $25 as of Q2 2026.
  • Sachetta left its Avanos Medical share count unchanged in Q2 2026.
  • Avanos Medical made up ﹤0.01% of Sachetta's portfolio in Q2 2026, its #1018 holding.
  • Sachetta first reported a position in Avanos Medical in Q4 2023 and has held it in 11 quarters since.
  • Sachetta's Avanos Medical position peaked at $315 in Q1 2024.
  • 26 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.